Drugs.com - Pharma Industry News

AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood Allergy

MONDAY, March 3, 2025 -- Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) of allergy-triggering foods after gaining tolerance, according to two studies presented at the...

Mar 3, 2025 - 21:21
 0
AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood Allergy
MONDAY, March 3, 2025 -- Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) of allergy-triggering foods after gaining tolerance, according to two studies presented at the...
Read More

Tags:

Previous Article

The Hottest Fragrances And Trends At Indie Perfume Shops Across The Country

Next Article

Air Force pauses deliveries of Boeing’s KC-46 tanker

Related Posts

Daily Screen Time Tied to Higher Myopia Risk

Daily Screen Time Tied to Higher Myopia Risk

Feb 25, 2025  0

Moderate, Heavy Alcohol Consumption Linked to Signs of Injury in the Brain

Moderate, Heavy Alcohol Consumption Linked to Signs of ...

Apr 11, 2025  0

Ultraprocessed Food Consumption in Early Childhood Tied to Obesity

Ultraprocessed Food Consumption in Early Childhood Tied...

Feb 9, 2025  0